[ad_1]
LOS ANGELES, CA –
Advanced simulations have shown that scaling up MIFTI’s fusion generator to 10 Mega Amps should achieve net energy gain and also allow for the commercial production of medical isotopes that are desperately needed for hospital cancer scanning. US Nuclear is a partner, investor, and possible prime contractor for MIFTI’s fusion power generator, and is looking forward to further developments.
Continuing breakthroughs in technology and a large influx of funding have rapidly accelerated fusion power development. Investment in the global fusion industry has skyrocketed, reaching a cumulative $6.21 billion, up from 4.8 billion just a year ago. Last year, Lawrence Livermore National Lab were the first to achieve positive net energy gain, paving the way towards the commercialization of fusion power, and Microsoft recently signed the world’s first deal to purchase commercial fusion energy from Helion Energy starting in 2028. MIFTI is unique in that they are the only company in the world that has developed a staged Z-pinch fusion method to the point of massive energy emission via neutron production. Their special approach has many advantages that will make them a leader in fusion power generation.
MIFTI was founded in 2008 by scientists from UC Irvine, who have spent over 25 years researching and developing their special Staged Z-pinch fusion technology. Years of experimentation, understanding, and advanced modeling have shown that MIFTI’s Z-pinch fusion approach can solve the world’s energy problems by providing a net energy gain from ten to fifty times the energy used to drive the process. In addition, the staged Z-pinch approach is very flexible and can be used for numerous applications, including the production of medical scanning isotopes and solving the worldwide multi-billion-dollar medical shortage.
Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at www.usnuclearcorp.com
CONTACT:
US Nuclear Corp. (OTC-QB: UCLE)
Robert I. Goldstein, President, CEO, and Chairman
Michael Hastings, Chief Financial Officer
(818) 883 7043
Email: info@usnuclearcorp.com
View the original release on www.newmediawire.com
[ad_2]